Skip to main content
Log in

Serum interleukin-6, interleukin-8, andβ 2-Microglobulin in early assessment of severity of acute pancreatitis comparison with serum C-reactive protein

  • Pancreatic And Biliary Disordes
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The aim of this study was to compare the sensitivity, specificity, and diagnostic accuracy of serum interleukin-6, interleukin-8,β 2-microglobulin, and C-reactive protein in the assessment of the severity of acute pancreatitis using commercial kits for their respective assays. Thirty-eight patients with acute pancreatitis (25 men, 13 women, mean age 59 years, range 16–97) were studied; the diagnosis was based on prolonged upper abdominal pain associated with a twofold increase of serum lipase, and it was confirmed by imaging techniques. According to the Atlanta criteria, 15 patients had severe illness and 23 had mild disease. The four serum markers were determined in all patients on admission, as well as daily for the following five days. On the first day of the disease, the sensitivity (calculated on patients with severe pancreatitis), specificity (calculated on patients with mild pancreatitis), and the diagnostic accuracy of these serum markers for establishing the severity of acute pancreatitis were 100%, 86%, and 91% for interleukin-6 (cutoff level 2.7 pg/ml); 100%, 81%, and 88% for interleukin-8 (cutoff level 30 pg/ml); 58%, 81%, and 73% forβ 2-microglobulin (cutoff level 2.1 mg/liter); and 8%, 95%, and 64% for C-reactive protein (cutoff level 11 mg/dl). The results of our study indicate that, when assayed during the first 24 hr of disease onset, interleukin-6 and interleukin-8 are better markers thanβ 2-microglobulin or C-reactive protein for evaluating the severity of acute pancreatitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Leser HG, Gross V, Scheibenbogen C, Heinisch A, Salm R, Lausen M, Ruckauer K, Andreesen R, Farthmann EH, Scholmerich J: Elevation of serum interleukin-6 concentration precedes acute-phase response and reflects severity in acute pancreatitis. Gastroenterology 101:782–785, 1991

    PubMed  Google Scholar 

  2. Viedma JA, Perez-Mateo M, Dominguez JE, Carballo F: Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Cut 33:1264–1267, 1992

    Google Scholar 

  3. Hamilton G, Hofbauer S, Hamilton B: Endotoxin, TNF-alpha, interleukin-6 and parameters of the cellular immune system in patients with intraabdominal sepsis. Scand J Infect Dis 24:361–368, 1992

    PubMed  Google Scholar 

  4. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW: Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 34:41–45, 1993

    PubMed  Google Scholar 

  5. Curley PJ, McMahon MJ, Lancaster F, Banks RE, Barclay GR, Shefta J, Boylston AW, Whicher JT: Reduction in circulating levels of CD4-positive lymphocytes in acute pancreatitis: Relationship to endotoxin, interleukin 6 and disease severity. Br J Surg 80:1312–1315, 1993

    PubMed  Google Scholar 

  6. Gross V, Andreesen R, Leser HG, Ceska M, Liehl E, Lausen M, Farthmann EH, Scholmerich J: Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 22:200–203, 1992

    PubMed  Google Scholar 

  7. Manicourt D, Brauman H, Orloff S: Plasma and urinary levels ofβ 2-M in rheumatoid arthritis. Ann Reum Dis 37:328–332, 1978

    Google Scholar 

  8. Descos L, Beorchia S, Vincent C, Revillard JP: Serum levels ofβ2M. A new marker of activity in Crohn's disease. N Engl J Med 301:440–441, 1979

    Google Scholar 

  9. Forman DT: Beta-2 microglobulin. An immunogenetic marker of inflammatory and malignant origin. Ann Clin Lab Sci 12:447–452, 1982

    PubMed  Google Scholar 

  10. Bradley EL: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11–13, 1992. Arch Surg 128:586–590, 1993

    PubMed  Google Scholar 

  11. Pezzilli R, Billi P, Fiocchi M, Beltrandi E, Cappelletti O, Sprovieri G, Miglioli M: Serumβ 2-microglobulin in chronic diseases of the pancreas. Int J Pancreatol 17:161–165, 1995

    PubMed  Google Scholar 

  12. Pezzilli R, Billi P, Platè L, Bongiovanni F, Morselli Labate AM, Miglioli M: Human pancreas-specific protein/procar-boxypeptidase B: A useful serum marker of acute pancreatitis. Digestion 55:73–77, 1994

    PubMed  Google Scholar 

  13. Lusted LB: Decision-making studies in patient management. N Engl J Med 284:416–424, 1971

    PubMed  Google Scholar 

  14. Robertson EA, Zweig MH: Use of receiver operating characteristic curves to evaluate the clinical performance of analystical systems. Clin Chem 27:1569–1574, 1981

    PubMed  Google Scholar 

  15. Turkey JW: Exploratory Data Analysis. Reading, Massachusetts: Addison-Wesley, 1977

    Google Scholar 

  16. Steinberg WM: Predictors of severity of acute pancreatitis. Gastroenterol Clin North Am 19:849–861, 1990

    PubMed  Google Scholar 

  17. Agarwal N, Pitchumoni CS: Assessment of severity in acute pancreatitis. Am J Gastroenterol 86:1385–1391, 1991

    PubMed  Google Scholar 

  18. Mayer AD, McMahon MJ, Bowen M, Cooper EH: C Reactive protein: An aid to assessment and monitoring of acute pancreatitis. J Clin Pathol 37:207–211, 1984

    PubMed  Google Scholar 

  19. Gross V, Scholmerich J, Leser HG, Salm R, Lausen M, Ruckauer K, Schoffel U, Lay L, Heinisch A, Farthmann EH: Granulocyte elastase in assessment of severity of acute pancreatitis. Comparison with acute-phase proteins C-reactive protein,α 1-antitrypsin, and protease inhibitorα 2-macroglobulin. Dig Dis Sci 35:97–105, 1990

    PubMed  Google Scholar 

  20. Buchler M, Malfertheiner P, Schadlich H, Nevalainen TJ, Friess H, Beger HG: Role of phospholipase A2 in human acute pancreatitis. Gastroenterology 97:1521–1526, 1989

    PubMed  Google Scholar 

  21. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J: Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 33:1126–1128, 1992

    PubMed  Google Scholar 

  22. Pezzilli R, Billi P, Platè L, Barakat B, Biongiovanni F, Miglioli M: Human pancreatic secretory trypsin inhibitor in the assessment of the severity of acute pancreatitis. A comparison with C-reactive protein. J Clin Gastroenterol 19:112–117, 1994

    PubMed  Google Scholar 

  23. Pezzilli R, Billi P, Gullo L, Beltrandi E, Malbini M, Mancini R, Incorvaia L, Miglioli M: Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Digestion 55:268–273, 1994

    PubMed  Google Scholar 

  24. Le J, Vilcek J: Biology of disease. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 61:588–602, 1989

    PubMed  Google Scholar 

  25. Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J: Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 104:1492–1497, 1993

    PubMed  Google Scholar 

  26. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL: Relationship of functional and antigenic interleukin 6 to disease activity in inflammatory bowel disease. Gastroenterology 104:1285–1292, 1993

    PubMed  Google Scholar 

  27. Deviere J, Content J, Crusiaux A, Dupont E: IL-6 and TNF-α in ascitic fluid during spontaneous bacterial peritonitis. Dig Dis Sci 36:123–124, 1991

    PubMed  Google Scholar 

  28. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ: High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 32:1531–1534, 1991

    PubMed  Google Scholar 

  29. Goodman AJ, Bird NC, Johnson AG: Antiprotease capacity in acute pancreatitis. Br J Surg 73:796–798, 1986

    PubMed  Google Scholar 

  30. Schulz HU, Schmidt D, Kunz D, Meyer F, Lippert H: Altered immune function in acute pancreatitis: Pathogenic role and prognostic indicator? Digestion 54:307–308, 1993

    Google Scholar 

  31. Nijsten MW, DeGroot ER, TenDuis HJ, Klesen HJ, Hack CE, Aarden LA: Serum levels of interleukin-6 and acute phase responses. Lancet 2:921, 1987

    PubMed  Google Scholar 

  32. Van Oers MHJ, van der Heyden AAPAM, Aarden LA: Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin Exp Immunol 71:314–319, 1988

    PubMed  Google Scholar 

  33. Rinderknecht H: Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 3:105–112, 1988

    PubMed  Google Scholar 

  34. Waage A, Brandtzaeg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin-6, interleukin-1, and fatal outcome. J Exp Med 169:333–338, 1989

    PubMed  Google Scholar 

  35. Nishimoto N, Yoshizaki K, Tagoh H, Monden M, Kishimoto S, Hirano T, Kishimoto T: Elevation of serum interleukin-6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol 50:399–401, 1989

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pezzilli, R., Billi, P., Miniero, R. et al. Serum interleukin-6, interleukin-8, andβ 2-Microglobulin in early assessment of severity of acute pancreatitis comparison with serum C-reactive protein. Digest Dis Sci 40, 2341–2348 (1995). https://doi.org/10.1007/BF02063235

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02063235

Key words

Navigation